TP-1454

· Sumitomo Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TP-1454, covering 2025-05-01 to 2025-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of Oral TP-1454 [Phase 1]